• LAST PRICE
    3.6300
  • TODAY'S CHANGE (%)
    Trending Down-0.0200 (-0.5479%)
  • Bid / Lots
    3.6100/ 3
  • Ask / Lots
    3.6500/ 2
  • Open / Previous Close
    3.6500 / 3.6500
  • Day Range
    Low 3.4400
    High 3.7400
  • 52 Week Range
    Low 1.0200
    High 8.1100
  • Volume
    67,261
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 3.65
TimeVolumeDERM
09:32 ET215993.48
09:33 ET68393.5
09:35 ET12893.58
09:37 ET26403.575
09:39 ET5003.6
09:42 ET1853.6
09:44 ET16423.64
09:48 ET11003.6
09:53 ET81973.62
09:55 ET33403.65
09:57 ET6003.68
10:02 ET4003.72
10:04 ET6853.72
10:15 ET1503.6601
10:29 ET32063.705
10:31 ET31563.68
10:36 ET8223.69
10:44 ET1003.74
10:47 ET1003.7314
10:54 ET5453.73
11:16 ET4003.73
11:39 ET21663.67
11:45 ET17903.65
11:52 ET11323.63
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDERM
Journey Medical Corp
45.7M
-4.3x
---
United StatesRMTI
Rockwell Medical Inc
35.9M
-2.3x
---
United StatesIPAH
Interpharm Holdings Inc
70.0
0.0x
---
United StatesPXYN
Praxsyn Corp
790.0
0.0x
---
United StatesCHME
China Medicine Corp
2.8K
0.0x
---
United StatesSCTL
Societal CDMO Inc
53.1M
-1.8x
---
As of 2024-02-26

Company Information

Journey Medical Corporation is a pharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes over eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products that have been approved by the United States Food and Drug Administration (FDA) for sale include Qbrexza, Accutane, Targadox, Ximino, and Exelderm Cream and Solution. The Company's product Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, which is an oral isotretinoin drug for the treatment of severe recalcitrant severe acne; Targadox, which is an oral doxycycline drug for adjunctive therapy for acne; Ximino, which is an oral minocycline drug for the treatment of moderate to severe acne, and Exelderm Cream and Solution is an antifungal intended for topical use.

Contact Information

Headquarters
9237 E Via De Ventura Blvd. Suite 105, Suite 105SCOTTSDALE, AZ, United States 85258
Phone
480-434-6670
Fax
302-531-3150

Executives

Executive Chairman of the Board
Lindsay Rosenwald
President, Chief Executive Officer, Director
Claude Maraoui
Interim Chief Financial Officer, Corporate Controller
Joseph Benesch
General Counsel, Corporate Secretary
Ramsey Alloush
Independent Director
Neil Herskowitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$45.7M
Revenue (TTM)
$79.9M
Shares Outstanding
12.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.84
Book Value
$0.96
P/E Ratio
-4.3x
Price/Sales (TTM)
0.6
Price/Cash Flow (TTM)
36.8x
Operating Margin
-12.47%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.